PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas

Mostrar otras versiones (1)
Detalles Bibliográficos
Autores principales: Black, Jonathan D, Lopez, Salvatore, Cocco, Emiliano, Bellone, Stefania, Altwerger, Gary, Schwab, Carlton L, English, Diana P, Bonazzoli, Elena, Predolini, Federica, Ferrari, Francesca, Ratner, Elena, Silasi, Dan-Arin, Azodi, Masoud, Schwartz, Peter E, Santin, Alessandro D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705897/
https://www.ncbi.nlm.nih.gov/pubmed/26625219
http://dx.doi.org/10.1038/bjc.2015.388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705897/
https://www.ncbi.nlm.nih.gov/pubmed/26625219
http://dx.doi.org/10.1038/bjc.2015.388

Ejemplares similares